Discover 1,781 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,781
Active & Responsive
Inspiring Seniors Towards Exercise Promotion to Protect Cognition
for
Alzheimer Disease, Physical Activity
1 location in Greensboro
Sponsor: Emory University
Sex: All
Age: 65+
Code: NCT06496425
Recruiting
Active & Responsive
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
1 location in Greensboro
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07266831
Phase2, Phase3, Recruiting
Active & Responsive
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
for
Human Immunodeficiency Virus (HIV),
1 location in Greensboro
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16+
Code: NCT07044297
Phase3, Recruiting
Active & Responsive
Clinical Evaluation of WaveLight Plus LASIK
for
Myopia, Astigmatism
1 location in Greensboro
Sponsor: Laser Defined Vision
Sex: All
Age: 18+
Code: NCT07127757
Recruiting
Active & Responsive
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
for
Migraine
1 location in Greensboro
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06417775
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
for
Pulmonary Nodule, Solitary, Lung Cancer
1 location in Greensboro
Sponsor: Veracyte, Inc.
Sex: All
Age: 29 - 70+
Code: NCT06426628
Recruiting
Active & Responsive
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
National Cancer Institute "Cancer Moonshot Biobank"
for
Acute Myeloid Leukemia,
1 location in Kernersville
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 13+
Code: NCT04314401
Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis